Asensus Surgical Financial Statements (ASXC)

Asensus Surgicalsmart-lab.ru %   2022 2022 2023 2023   LTM ?
Report date 30.06.2022 31.12.2022 02.03.2023 21.03.2024 29.04.2024   13.08.2024
Currency USD USD USD USD USD   USD
Financial report URL  
Revenue, bln rub ? 7.09 7.09 8.58 8.58   14.2
Operating Income, bln rub -75.7 -75.7 -78.1 -78.1   -66.7
EBITDA, bln rub ? -63.8 -64.3 -74.4 -74.4   -62.8
Net profit, bln rub ? -75.6 -75.6 -78.4 -78.4   -82.7
OCF, bln rub ? -58.9 -58.9 -63.6 -63.6   -55.0
CAPEX, bln rub ? 1.28 1.28 0.561 0.561   0.257
FCF, bln rub ? -60.2 -60.2 -64.2 -64.2   -55.2
Dividend payout, bln rub 0.000 0.000 0.000 0.000   0.000
Ordinary share dividend yield, % 0.00% 0.00% 0.00% 0.00% 0.00%  
Dividend payout ratio, % 0.00% 0.00% 0.00% 0.00%   0
OPEX, bln rub 71.9 71.6 73.1 73.1   66.2
Cost of production, bln rub 10.9 10.9 13.6 13.6   14.7
R&D, bln rub 28.9 28.9 37.0 37.0   32.9
Interest expenses, bln rub 0.410 0.410 0.000 0.000   0.499
Assets, bln rub 147.4 116.1 116.1 60.5 60.5   38.5
Net Assets, bln rub ? 131.4 99.6 99.6 33.4 33.4   -11.3
Debt, bln rub 5.19 5.54 5.54 5.68 5.68   20.4
Cash, bln rub 94.2 70.5 70.5 21.1 21.1   7.78
Net debt, bln rub -89.0 -65.0 -65.0 -15.4 -15.4   12.7
Ordinary share price, rub 0.400 0.347 0.347 0.319 0.319  
Number of ordinary shares, mln 236.5 236.5 249.7 249.7   272.3
Market cap, bln rub 0 82 82 80 80   0
EV, bln rub ? -89 17 17 64 64   13
Book value, bln rub 131 100 98 32 32   -11
EPS, rub ? -0.32 -0.32 -0.31 -0.31   -0.30
FCF/share, rub -0.25 -0.25 -0.26 -0.26   -0.20
BV/share, rub 0.42 0.41 0.13 0.13   -0.04
EBITDA margin, % ? -899.6% -907.1% -867.4% -867.4%   -442.4%
Net margin, % ? -1 066% -1 066% -914.5% -914.5%   -582.8%
FCF yield, % ? 0.00% -73.4% -73.4% -80.6% -80.6%  
ROE, % ? 0.00% -75.8% -75.8% -234.7% -234.7%   730.3%
ROA, % ? 0.00% -65.1% -65.1% -129.6% -129.6%   -214.8%
P/E ? -1.09 -1.09 -1.02 -1.02   0
P/FCF -1.36 -1.36 -1.24 -1.24   0
P/S ? 11.6 11.6 9.28 9.28   0
P/BV ? 0.00 0.82 0.84 2.47 2.47   0
EV/EBITDA ? -0.27 -0.27 -0.86 -0.86   -0.20
Debt/EBITDA 1.02 1.01 0.21 0.21   -0.20
R&D/CAPEX, % 2 263% 2 263% 6 599% 6 599%   12 821%
CAPEX/Revenue, % 18.0% 18.0% 6.54% 6.54%   1.81%
Asensus Surgical shareholders